National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 2,908 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 18 out of 291

Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next


VAERS ID: 1084861 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-30
   Days after onset: 29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Cardiac insufficiency; COVID-19
Preexisting Conditions: Medical History/Concurrent Conditions: Viral hepatitis B
Allergies:
Diagnostic Lab Data: Test Date: 20210125; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ATPFIZER INC2021221786

Write-up: COVID-19 respiratory infection; This is a spontaneous report a contactable physician downloaded from the Regulatory Authority [regulatory authority AT-BASGAGES-2021-04880]. The reporter reported similar events for 2 patients, this is the 1st of 2 reports. A 90-year-old female patient received the first dose of bnt162b2 (COMIRNATY, lot number EL1491) via an unspecified route of administration on 15Jan2021 at a single dose for covid-19 immunisation. The patient''s medical history included Heart failure (continuing), Viral hepatitis B, COVID-19 (continuing). The patient''s concomitant medications were not reported. The patient was positive tested for Sars-CoV2 by means of PCR (25Jan), on 30Jan2021 21:05 and died in the home from COVID-19 respiratory infection. The patient was already palliative before COVID-19 and considered as a terminal patient. No autopsy was done. Causality between the event and vaccine was assessed as unlikely by the HA. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : AT-PFIZER INC-2021242520 same reporter, same vaccine, similar events in different patient; Reported Cause(s) of Death: COVID-19 respiratory infection


VAERS ID: 1084862 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-02-01
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-11
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Breast carcinoma (Mammary gland right)
Preexisting Conditions: Medical History/Concurrent Conditions: Infarct cerebral (ischemic infarction)
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ATPFIZER INC2021221799

Write-up: SARS-COV2-POSITIVE INFECTION/ COVID-19 respiratory infection/ COVID-19; SARS-COV2-POSITIVE INFECTION/ COVID-19 respiratory infection/ COVID-19; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB regulatory authority AT-BASGAGES-2021-04886. A 94-year-old female patient received bnt162b2 (COMIRNATY, lot/batch number: EL1491) , via an unspecified route of administration on 15Jan2021 at single dose for COVID-19 immunisation . Medical history included ongoing breast carcinoma (Mammary gland right) and Infarct cerebral (ischemic infarction) from an unspecified date and not ongoing. The patient''s concomitant medications were not reported. The patient experienced sars-cov2-positive infection/ covid-19 respiratory infection/ covid-19 (drug ineffective) (death) on Feb2021. The patient underwent lab tests and procedures which included COVID-19 PCR test: positive on 05Feb2021. Narrative case summary and further information was reported as "possible association between deaths and COVID vaccinations given promptly before is suspected. The individuals were all vaccinated against COVID-19 on Jan152021 (1st partial vaccination with Comirnaty, batch EL1491), tested positive 4 to 13 days later (One patient 32 days later), and died 10 to 20 days after vaccination (said patient 37 days later). A similar cluster of deaths did not occur at the nursing home in recent years. COVID infection has been circulating in the home since 01Jan2021. All 12/14 decedents have tested positive for Sars-CoV2 by PCR. The patient in this NW report also tested pos. for Sars-CoV2 by PCR (05Feb2021), then died at the home on 11Feb2021. " The patient died on 11Feb2021 from COVID-19. An autopsy was not performed. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: SARS-COV2-POSITIVE INFECTION/ COVID-19 respiratory infection/ COVID-19


VAERS ID: 1084863 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-02-16
   Days after vaccination:32
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210216; Test Name: Covid-19; Result Unstructured Data: Test Result:positive
CDC Split Type: ATPFIZER INC2021242520

Write-up: drug ineffective; COVID-19; This is a spontaneous report a contactable physician reporting on different patients, this is the second case. The first case report was downloaded from the Regulatory Authority [regulatory authority AT-BASGAGES-2021-04880]. A elderly patient of an unspecified gender received the first dose bnt162b2 (COMIRNATY; Lot # EL1491) vaccine , via an unspecified route of administration 15Jan2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was tested positive to SARS-COV-2 on 16Feb2021 and died from it on 21Feb2021. It is unknown if an autopsy was carried out. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : AT-PFIZER INC-2021221786 same reporter, same vaccine, similar events in different patient.; Reported Cause(s) of Death: Covid-19


VAERS ID: 1084890 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-01-26
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test, SARS-CoV-2 test positive
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-27
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: AFib; Dementia; Diabetes
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210126; Test Name: COVID-19 PCR test; Test Result: Positive ; Comments: no variant search
CDC Split Type: FRPFIZER INC2021232874

Write-up: symptoms of COVID-19 appeared; symptoms of COVID-19 appeared and performance of a positive PCR test (no variant search); This is a spontaneous report from a contactable physician downloaded from the regulatory authority. The regulatory Authority Report Number is FR-AFSSAPS-MP20210276. A 93-year-old female patient received the first dose of bnt162b2 (COMIRNATY; lot number EJ6788), intramuscular in the left arm on 21Jan2021 at a single dose for covid-19 immunisation. Medical history included ongoing diabetes, ongoing dementia, and ongoing Afib. The patient''s concomitant medications were not reported. Declaration made through the national portal, made by a health professional. Patient considered to be at risk of developing a severe form of COVID-19 disease was yes (age). History of COVID-19 was not specified. Patient was vaccinated on 21Jan2021 as part of the COVID-19 vaccination campaign. On 26Jan2021, symptoms of COVID-19 appeared and performance of a positive PCR test (no variant search). Patient was treated in the nursing home. On 27Jan2021, the patient died. Accountability made without prejudice to the elements of investigations which could be carried out within the framework of legal or amicable compensation procedures. It was not reported if an autopsy was performed. The events are serious, fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: symptoms of COVID-19; positive PCR test


VAERS ID: 1084891 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-01-25
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-28
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Epilepsy
Preexisting Conditions: Medical History/Concurrent Conditions: CVA; Dementia
Allergies:
Diagnostic Lab Data: Test Date: 20210125; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021232855

Write-up: COVID-19 PCR test positive/ COVID-19 aggravated; This is a spontaneous report from a contactable physician downloaded from Regulatory Authority, regulatory authority FR-AFSSAPS-MP20210278. A 77-year-old male patient received first dose of BNT162B2 (COMIRNATY; lot number: EJ6788) on left arm, intramuscular on 21Jan2021 at single dose for COVID-19 immunisation. Medical history included ongoing epilepsy, cerebrovascular accident (CVA) from 2011 to 2013, and dementia. The patient''s concomitant medications were not reported. The patient experienced COVID-19 PCR test positive and COVID-19 aggravated on 25Jan2021. The patient was considered to be at risk of developing a severe form of COVID-19 disease. The patient was vaccinated as part of the COVID-19 vaccination campaign. It was also reported that on 25Jan2021, symptoms of COVID-19 appeared. Additionally on 25Jan2021, performance of a positive PCR test (no variant search). Patient was treated in the nursing home. On 28Jan2021, death of the patient. The patient died on 28Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 PCR test positive


VAERS ID: 1086537 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-26
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Dyspnoea, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-29
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210126; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ATPFIZER INC2021242195

Write-up: acute shortness of breath, immediately transferred to the hospital; Death NOS; COVID-19 respiratory infection; This is a spontaneous report downloaded from the regulatory authority-WEB [Regulatory Authority number AT-BASGAGES-2021-04883] from a contactable physician. An 87-year-old female patient received the 1st dose of bnt162b2 (COMIRNATY) (lot# EL1491), via an unspecified route of administration, on 15Jan2021, at single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced death NOS (death) on 29Jan2021, acute shortness of breath, immediately transferred to the hospital (death, caused hospitalization on 27Jan2021) on 27Jan2021, COVID-19 respiratory infection (death) on 26Jan2021. The patient underwent lab tests and procedures which included COVID-19 PCR test: positive on 26Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 respiratory infection; Acute dyspnea; Death NOS


VAERS ID: 1086549 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-04
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Oxygen saturation abnormal
SMQs:, Lack of efficacy/effect (narrow), Acute central respiratory depression (broad), Respiratory failure (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021236701

Write-up: COVID-19 16day infection after vaccination; COVID-19 16day infection after vaccination; putting on high flow oxygen, then going to intensive care.; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) WEB BE-FAMHP-DHH-N2021-79019. A 76-years-old male patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine (COMIRNATY), Lot# EM0477, via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. It was reported that on 04Feb2021 the patient was put on high flow oxygen due to oxygen saturation abnormal, then he went to intensive care. The following was also reported: "COVID-19 16day infection after vaccination requiring hospitalization with high-flow oxygen". On an unspecified date few days after admission the patient died. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Oxygen saturation abnormal


VAERS ID: 1086550 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-02-08
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, General physical health deterioration, Renal failure, Respiratory distress
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (broad), Chronic kidney disease (narrow), Hypersensitivity (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: BELLOZAL; TAMSULOSIN; OLANZAPINE; LORAZEPAM; PARACETAMOL; MELATONINE; PRAZEPAM; DESMOPRESSIN; HALDOL; QUETIAPIN; CALCIFEROL [COLECALCIFEROL]; INDAPAMIDE; L-THYROXINE [LEVOTHYROXINE]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Benign prostatic hyperplasia; Chronic renal failure worsened; Mental retardation; Osmolality abnormal NOS; Paranoid schizophrenia; Smoker
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021236705

Write-up: COVID-19; COVID-19; Respiratory distress; Renal failure; General physical health deterioration; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB regulatory authority BE-FAMHP-DHH-N2021-79023. A 68-year-old male patient received first dose bnt162b2 (COMIRNATY, lot: EM0477), via an unspecified route of administration on 18Jan2021 at single dose for covid-19 immunisation. Medical history included Mental retardation, paranoid schizophrenia, potomania, severe chronic renal failure, benign prostatic hyperplasia, heavy smoking. Concomitant medication included bilastine (BELLOZAL), tamsulosin, olanzapine, lorazepam, paracetamol, melatonine, prazepam, desmopressin, haloperidol (HALDOL), quetiapine fumarate (QUETIAPIN), colecalciferol (CALCIFEROL), indapamide, levothyroxine (L-THYROXINE). The patient experienced respiratory distress, renal failure, general physical health deterioration, covid-19, all on 08Feb2021 with fatal outcome. It was reported that severe Covid-19 infection requiring hospitalization for respiratory distress and deterioration of general condition, aggravation of respiratory distress and increase in renal failure requiring intensive care. The patient died on an unspecified date in 2021. It was not reported if an autopsy was performed. BNT162B2 for all events reported by FAMHP as unlikely. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: covid-19; covid-19; respiratory distress; renal failure; general physical health deterioration


VAERS ID: 1086568 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-27
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Coronavirus test, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: routine rapid test; Test Result: Positive
CDC Split Type: DEPFIZER INC2021241865

Write-up: routine rapid tests was positive; routine rapid tests was positive; This is a spontaneous report from a contactable physician. A 94-years-old female patient received first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 27Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The 94-year-old woman who died in the days that followed in 2021, routine rapid tests was positive 2021. The patient underwent lab tests and procedures which included coronavirus test: positive on 2021. The patient died in 2021. It was not reported if an autopsy was performed. It was reported that: residents and staff in a nursing home were administered the first dose of Comirnaty on 27Jan2021. During routine rapid tests in the days that followed, a large number of residents and staff were positive. Most of these were asymptomatic or with only minor symptoms of illness, and none required hospitalization. In the end, there was a 94-year-old woman who died in the days that followed. The physician assume that the germ was already in the house in the run-up to the vaccination. In his/her opinion, the vaccination had the effect that there were no severe courses. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender''s Comments: Based on the information available, a causal association between BNT162b2 and the reported event cannot be excluded. The patient''s immunocompromised state due to age and the current pandemic may provide an alternative explanation for the events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: there was a 94-year-old woman who died in the days that followed; there was a 94-year-old woman who died in the days that followed


VAERS ID: 1086668 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-27
Onset:2021-02-05
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cough, Decreased appetite, Oxygen saturation, Oxygen saturation decreased, Pyrexia
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-13
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia; Diabetes; Hypertension arterial; Hypothyroidism; Iron deficiency anemia; Psychosis
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: Oxygen saturation; Test Result: 91 %; Test Date: 20210205; Test Name: Fever; Result Unstructured Data: Test Result:38 and 39 Centigrade
CDC Split Type: FRPFIZER INC2021232907

Write-up: COVID-19 aggravated; fever between 38 and 39 C; desaturation (91%); loss of appetite; isolated cough; This is a spontaneous report from a contactable physician from the Medicines Agency (MA)WEB. The Regulatory Authority report number is FR-AFSSAPS-RS20210256. A 71-year-old male patient received the first dose of BNT162B2 (COMIRNATY, lot number: EJ6788, expiration date not reported), intramuscular in the left arm on 27Jan2021 at a single dose for COVID-19 immunisation. Medical history included Hypertension arterial, Iron deficiency anemia, arrhythmia, Diabetes, Delusional psychosis, and hypothyroidism. The patient''s concomitant medications were not reported. The patient is considered to be at risk of developing a severe form of COVID19 disease (diabetes, heart disease). The patient experienced COVID-19 aggravated on 05Feb2021. It was further reported that on 05Feb2021, onset of fever between 38 and 39 C, desaturation (91%), loss of appetite and isolated cough. The patient was hospitalized on an unspecified date in Feb2021 due to the events. On 13Feb2021, death of the patient due to complicated COVID following according to the declaring doctor. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: isolated cough; COVID-19 aggravated; fever between 38 and 39 C; desaturation (91%); loss of appetite


Result pages: prev   9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=18&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166